Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: Int J Cancer. 2010 Apr 15;126(8):1788–1796. doi: 10.1002/ijc.24689

Table 2.

Incidence and multiplicity of P-GST positive AHF (n=8/group)

P-GST (+) altered hepatic foci
Group Incidence1 Multiplicity2
CD 1/8 0.10 ± 0.03
CD+LY 1/8 0.07 ± 0.02
CD+TE 1/8 0.15 ± 0.07
HFD 5/8 1.25 ± 0.05b
HFD+LY 1/8 0.17 ± 0.06a
HFD+TE 1/8 0.16 ± 0.04a
1

The overall P = 0.83 indicating no significant difference among all groups by using Cochran-Mantel-Haenszel Statistic test

2

Values are presented as means ± SEM, n=8. Kruskal-Wallis overall test followed by Wilcoxon rank-sum test was used for multiple comparisons within either CD-fed groups or HFD-fed groups; values bearing different letter superscripts were significantly different (P < 0.01)